Position in INDV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,816,019
+$463,719 QoQ
Shares Held
117,378
-17.8% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#90
of 334 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INDV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PDT Partners, LLC holds $16,723,036 across 8 Drug Manufacturers - Specialty & Generic names. INDV ranks #1 (28.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
This page
|
117,378 | $4,816,019 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
|
45,442 | $3,761,688 | |
| 3 | PCRX |
Pacira BioSciences, Inc.
|
132,368 | $3,358,176 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
40,567 | $2,594,259 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
25,858 | $1,202,655 | |
| 6 | ETON |
Eton Pharmaceuticals, Inc.
|
14,891 | $539,054 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
24,489 | $244,890 | |
| 8 | BHC |
Bausch Health Companies Inc.
|
41,845 | $206,295 |
All Filings in INDV
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,816,019 | 117,378 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,352,300 | 142,792 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||